Cardiol Therapeutics Inc. (CRDL)

Cardiol Therapeutics Statistics

Total Valuation

CRDL has a market cap or net worth of $99.74 million. The enterprise value is $91.34 million.

Market Cap	99.74M
Enterprise Value	91.34M

Important Dates

The last earnings date was Thursday, November 13, 2025, after market close.

Earnings Date	Nov 13, 2025
Ex-Dividend Date	n/a

Share Statistics

CRDL has 87.46 million shares outstanding. The number of shares has increased by 21.91% in one year.

Current Share Class	98.86M
Shares Outstanding	87.46M
Shares Change (YoY)	+21.91%
Shares Change (QoQ)	+2.51%
Owned by Insiders (%)	3.45%
Owned by Institutions (%)	10.43%
Float	95.43M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	14.53
P/TBV Ratio	14.53
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 3.89, with a Debt / Equity ratio of 0.01.

Current Ratio	3.89
Quick Ratio	3.59
Debt / Equity	0.01
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -347.98% and return on invested capital (ROIC) is -223.45%.

Return on Equity (ROE)	-347.98%
Return on Assets (ROA)	-148.83%
Return on Invested Capital (ROIC)	-223.45%
Return on Capital Employed (ROCE)	-375.59%
Revenue Per Employee	n/a
Profits Per Employee	-$1.39M
Employee Count	18
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -21.18% in the last 52 weeks. The beta is 0.82, so CRDL's price volatility has been lower than the market average.

Beta (5Y)	0.82
52-Week Price Change	-21.18%
50-Day Moving Average	1.05
200-Day Moving Average	1.14
Relative Strength Index (RSI)	44.96
Average Volume (20 Days)	633,417

Short Selling Information

The latest short interest is 2.25 million, so 2.57% of the outstanding shares have been sold short.

Short Interest	2.25M
Short Previous Month	1.89M
Short % of Shares Out	2.57%
Short % of Float	2.36%
Short Ratio (days to cover)	3.19

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-26.04M
Pretax Income	-24.97M
Net Income	-24.97M
EBITDA	-26.14M
EBIT	-26.04M
Earnings Per Share (EPS)	-$0.30

Balance Sheet

The company has $8.34 million in cash and $96,346 in debt, giving a net cash position of $8.25 million or $0.09 per share.

Cash & Cash Equivalents	8.34M
Total Debt	96,346
Net Cash	8.25M
Net Cash Per Share	$0.09
Equity (Book Value)	6.86M
Book Value Per Share	0.08
Working Capital	6.83M

Cash Flow

In the last 12 months, operating cash flow was -$17.39 million and capital expenditures -$19,783, giving a free cash flow of -$17.72 million.

Operating Cash Flow	-17.39M
Capital Expenditures	-19,783
Free Cash Flow	-17.72M
FCF Per Share	-$0.20

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

CRDL does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-21.91%
Shareholder Yield	-21.91%
Earnings Yield	-25.04%
FCF Yield	-17.77%

Analyst Forecast

The average price target for CRDL is $9.00, which is 806.25% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$9.00
Price Target Difference	806.25%
Analyst Consensus	Strong Buy
Analyst Count	2
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	2